Dario Amodei 就 Anthropic IPO 发文:称 AI 可压缩百年科学进展
Anthropic 要上市了,CEO 亲自下场讲故事。讲了他家 Claude 在药物研发里帮科学家省时间的用法,也承认了失控风险。想理解这家公司上市怎么跟投资人叙事、跟 OpenAI 打差异化,这篇原文值得翻一下。
Anthropic CEO Dario Amodei 在公司宣布首次公开募股之际发表声明,解释创始初心与公司愿景。他提及与共同创始人 Daniela 曾因父亲在疾病被治愈前几年去世的经历投身科学,认为智能是推动医学突破的核心。他引用 CRISPR 从发现 DNA 重复序列到首个疗法获批历时多年的例子,说明从想法到治疗往往需要数十年。
Amodei 表示,科学家已在蛋白质折叠、药物设计、癌症遗传学、临床试验管理等领域使用 Claude 加速研究,并称足够强大的 AI 与人类协作可将一个世纪的科学和医学进展压缩到十年内。他同时承认目前只有早期结果,实验和临床试验仍需时间。
声明还涉及风险讨论:滥用、经济冲击、AI 失控等,他认为这些风险可避免,取决于 AI 开发者的选择。声明面向客户、投资者和公众,为上市叙事定调。
Remarks from Anthropic CEO @DarioAmodei on our initial public offering: My co-founders and I started Anthropic because we believe that the most powerful technology of our time should be built for the benefit of humankind. Daniela and I lost our father to a disease that, just a few years later, became curable. I started my career in biology, hoping to help future cures come sooner. In the lab, I saw the vast thicket of complexity that scientists face when they’re trying to understand disease and develop new treatments. So many of the scientific tools that can cut through that thicket—tools for gene editing, gene synthesis, controlling brain cells with light—started as pure ideas. In other words, they came from thinking. From intelligence. Human intelligence has already made diseases like plague, smallpox, and polio history for most of the world. But progress on other diseases has been too slow for so many patients and their families. Going from a great idea to a treatment can take decades: it took many years from the first discovery of a strange repeating pattern in DNA to the approval of the first treatment for a disease using CRISPR. Nature is full of these patterns. But we’ve had too little intelligence to decipher most of them; too few scientists, with too little time. Now we can build that intelligence. Whether it’s protein folding, drug design, cancer genetics, or clinical trial administration, scientists across many areas of biology and medicine are finding Claude can help them do their research in a fraction of the time it would’ve taken just a couple of years ago. I believe sufficiently powerful AI, working in concert with humans, could compress a century of scientific and medical progress into a decade. I don’t want to get ahead of myself. At this point all we have are early results. Experiments and clinical trials will still take time. And although they involve slow and ponderous processes, I believe those processes can be substantially accelerated by AI. We hope that in the future fewer families miss a cure by just a few years. Medicine is just a particularly vivid example, but there are many others. Our customers—the world’s most ambitious companies, nonprofits, and individual people—are already applying the intelligence we’ve built to stimulate economic growth; lift people out of poverty; protect democracy and free societies; even make everyday services like the DMV work better. We’re proud to work alongside them. And I’m extremely optimistic about what we can do together in the future. At the same time, we have always been honest that this technology has very real risks. These range from misuse of the technology by individuals or nation-states, to economic disruption, to losing control of AI systems. We discuss these risks not because we think they are inevitable, but because we think they are avoidable. Avoiding them depends on the choices made by the people building AI. There is a gigantic difference between how AI will go if we pay little attention to safety, versus how it will go if we are obsessed with safety. And an obsession with safety and with public benefit has been woven into Anthropic’s DNA from the start. From safeguards against biological and cyber risks, to alignment training and testing, to looking inside our models like an X-ray, Anthropic has pioneered methods for understanding and steering the behavior of AI systems. There is much work still to be done, and the most difficult safety work lies ahead of us. The incredible talent of the company that has enabled us to build the most capable AI systems will need to be directed, even more so than it has already, towards double- and triple-checking that those AI systems are safe and secure. And to state it unequivocally, we will pace the training and deployment of AI systems, taking as long as is necessary to have confidence that they are safe and will remain under human control. We will not bend to either business or political pressure. Today puts the company in a stronger financial position, and in doing so only strengthens our resolve to do the right thing. If we can show it’s possible to make the right choices on safety and still build an incredibly successful company, others in our industry will be inspired to do the same. We call this a race to the top. When the race to the top is working properly, it doesn’t matter which company has the best models—everyone wins because everyone is building safely. The race to the top works best when driven from the front of the pack, and we fully hope and expect to do so, but the goal is to make the whole industry better, regardless of whether Anthropic is winning or losing at any given time. The advent of machine intelligence is one of the seminal moments in human history, and we have a rare opportunity to shape it for the better. This moment is bigger than any one company, or any one country. It will take all of us, working together, to ensure this technology goes well for us and the many generations to come. Starting today, we hope that you’ll join us on this mission.📊 685 ⚡
This report is categorized under AITOP's "Industry" desk, focusing on US frontier AI labs and Silicon Valley technology leaders. Within our cross-regional analytical framework, it directly maps to US-China foundation model benchmarks and commercialization comparison. Key entities and technical topics under continuous tracking include Anthropic, Dario Amodei, IPO, Claude.
Source attribution: curated from Anthropic (@AnthropicAI). Cross-source corroboration: 11 independent sources have covered this development (including AI Will, techcrunch, PolymarketMoney), confirming industry-wide signal strength.